Venture Capital

The NYC health giant is using an AI platform to find millions in savings, aiming to reinvest the money back into patient care and infrastructure.

With $7M from True Ventures, a Thiel Fellow's startup is building AI 'ops agents' to help America's small factories finally compete on a global scale.

Dave Asprey’s 2026 BEYOND conference adds star power and a focus on consciousness, but how much is science versus high-tech hype?

A new venture from Mythical Games alumni is using agentic AI to transform sports viewing into an interactive game, starting with ONE Championship.

With a new commercial expert at the helm and its founder leading tech, UgoWork is poised for aggressive growth in the booming industrial EV market.

Astound names Ettienne Brandt CEO as it prepares to merge with GFiber, a move set to create the largest independent fiber provider in the U.S.

The FDA grants PolyPid a crucial $4.3 million fee waiver for its D-PLEX₁₀₀ drug, freeing up vital cash to accelerate its commercial launch.

Global financial services firm Ocorian launches a CFO Solutions office in Dallas, signaling the city's rise as a top private capital market.

The fast-growing vet chain hits a major milestone, but its venture-backed model reveals both the future of pet care and the challenges of rapid growth.

A new Philadelphia facility from Bill Gates' TerraPower aims to increase production of a rare cancer-fighting isotope by 20-fold, breaking a major bottleneck.

As AI valuations soar and IPOs loom, one veteran wealth manager warns of a familiar pattern. Are we witnessing innovation or another dot-com-style bubble?

Exiting stealth, PerturbAI releases an 8-million-cell map of gene function in a living brain, aiming to slash the cost and time of creating new drugs.

Backed by dialysis giants DaVita and U.S. Renal Care, a new startup licenses a first-in-class therapy to transform treatment for kidney patients.

Qblox's new Massachusetts facility marks a key step for 'Made in America' quantum tech, aiming to enhance U.S. competitiveness and supply chain security.

BioCardia's FDA milestone for its Helix catheter could unlock a new era of targeted heart therapies, but financial hurdles and clinical questions remain.

Facing financial headwinds, Lulus is betting big on wholesale. Can new deals with Amazon and Victoria's Secret secure its future in fashion?

A new biotech firm unveils a first-in-class cancer drug targeting E6AP, aiming to restore the body's natural defenses against HPV-positive head and neck cancer.

Facing a challenging EV market, Aspen Aerogels looks to the Roth Conference to showcase its long-term growth strategy and advanced aerogel technology.

Hyundai Motor Group and NVIDIA are expanding their partnership, aiming to dominate the future of autonomous vehicles with a data-driven, two-pronged strategy.

From a government office to a tech startup, the public has spoken. See the seven diverse companies crowned as favorites in the Asia-Pacific Stevie Awards.